الاتحاد الأوروبي - الهولندية - EMA (European Medicines Agency)

eli lilly nederland b.v. - abemaciclib - neoplasmata van de borst - antineoplastische middelen - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.

الاتحاد الأوروبي - الهولندية - EMA (European Medicines Agency)

eli lilly nederland b.v. - selpercatinib - carcinoma, non-small-cell lung; thyroid neoplasms - antineoplastische middelen - retsevmo as monotherapy is indicated for the treatment of adults and adolescents 12 years and older with advanced ret-mutant medullary thyroid cancer (mtc)advanced ret fusion-positive non-small cell lung cancer (nsclc) not previously treated with a ret inhibitoradvanced ret fusion-positive thyroid cancer who require systematic therapy following prior treatment.

الاتحاد الأوروبي - الهولندية - EMA (European Medicines Agency)

eli lilly nederland b.v. - tirzepatide - diabetes mellitus, type 2 - geneesmiddelen die worden gebruikt bij diabetes - mounjaro is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications- in addition to other medicinal products for the treatment of diabetes. for study results with respect to combinations, effects on glycaemic control and the populations studied, see sections 4. 4, 4. 5 en 5.

الاتحاد الأوروبي - الهولندية - EMA (European Medicines Agency)

eli lilly nederland b.v. - lasmiditan succinate - migraine stoornissen - pijnstillers - rayvow is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.

الاتحاد الأوروبي - الهولندية - EMA (European Medicines Agency)

eli lilly nederland b.v. - mirikizumab - colitis, ulcerative - immunosuppressiva - omvoh is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic treatment.

الاتحاد الأوروبي - الهولندية - EMA (European Medicines Agency)

eli lilly nederland b.v. - pirtobrutinib - lymfoom, mantel-cel - proteïne kinase remmers - treatment of mantle cell lymphoma (mcl).

الاتحاد الأوروبي - الهولندية - EMA (European Medicines Agency)

eli lilly nederland b.v. - dulaglutide - diabetes mellitus, type 2 - drugs used in diabetes, blood glucose lowering drugs, excl. insulins - trulicity is indicated for the treatment of patients 10 years and above with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes. voor het onderzoek naar de resultaten met betrekking tot combinaties, effecten op de glycemische controle en cardiovasculaire gebeurtenissen, en de bestudeerde populaties, zie punt 4. 4, 4. 5 en 5.

هولندا - الهولندية - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

teva nederland b.v. swensweg 5 2031 ga haarlem - celiprololhydrochloride 200 mg/stuk samenstelling overeenkomend met ; celiprolol 182,5 mg/stuk - filmomhulde tablet - cellulose, microkristallijn (e 460(i)) ; chinolinegeel aluminiumlak (e 104) ; croscarmellose natrium (e 468) ; dimeticon (e 900) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; macrogol 6000 ; macrogolstearylether ; magnesiumstearaat (e 470b) ; mannitol (d-) (e 421) ; ponceau 4r aluminiumlak (e 124) ; siliciumdioxide, gehydrateerd (e 551) ; sorbinezuur (e 200) ; talk (e 553 b) ; titaandioxide (e 171), cellulose, microkristallijn (e 460) ; chinolinegeel aluminiumlak (e 104) ; croscarmellose natrium (e 468) ; dimeticon (e 900) ; hypromellose, type 2910 (3 - 15 mpa.s) (e 464) ; macrogol 6000 ; macrogolstearylether ; magnesiumstearaat (e 470b) ; mannitol (d-) (e 421) ; ponceau 4r aluminiumlak (e 124) ; siliciumdioxide, gehydrateerd (e 551) ; sorbinezuur (e 200) ; talk (e 553 b) ; titaandioxide (e 171), cellulose, microkristallijn (e 460) ; chinolinegeel (e 104) ; croscarmellose natrium (e 468) ; dimeticon (e 900) ; hypromellose (e 464) ; macrogolstearylether ; magnesiumstearaat (e 470b) ; mannitol (d-) (e 421) ; polyethyleenglycol (e 1521) ; ponceau 4r (e 124) ; silica, hydrate form unknown (e 551) ; silicone antifoam emulsion se 2 {mixture of 5 ingredients of which 4 solid} (ri) ; sorbinezuur (e 200) ; talk (e 553 b) ; titaandioxide (e 171), - celiprolol

الاتحاد الأوروبي - الهولندية - EMA (European Medicines Agency)

chemical works of gedeon richter plc. (gedeon richter plc.) - ganirelix acetate - reproductive techniques, assisted; ovulation induction; infertility, female - hypofyse en hypothalamische hormonen en analogen - prevention of premature luteinising hormone (lh) surges in women undergoing controlled ovarian hyperstimulation (coh) for assisted reproduction techniques (art).

هولندا - الهولندية - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

nextmune b.v. - epithelia allergenen - oplossing voor injectie - epithelia allergenen 100 µg/ml, - allergens - honden